MEETINGS - Innovation and the Future: A Medical Technology Agenda (US) March 2000:
This article was originally published in Clinica
Executive Summary
The US Health Industry Manufacturers Association (HIMA) will hold its 26th annual meeting entitled Innovation and the Future: A Medical Technology Agenda in Phoenix, Arizona on March 22-25. The conference will include updates on the latest in regulatory and legislative trends; Medicare reform and its impact on payment and reimbursement; marketing and distribution issues; and empowerment of healthcare consumers. For more information contact HIMA in the US. Tel: +1 202 434 7243. Fax: +1 202 783 8750. Email: [email protected]
You may also be interested in...
Keeping Track: Cancer Approvals From Lumisight Imaging To Adjuvant Alecensa
The US FDA’s approval of Lumicell’s optical imaging agent Lumisight makes a dozen novel approvals in 2024 for the Center for Drug Evaluation and Research.
Partisan Politics Returns To US FDA Congressional Oversight
The US FDA has stood out as an agency that tends to draw broad bipartisan support amid a generally rancorous and divided Congress. A House hearing, however, may be a sign that those days are over.
GLP-1 Coverage Restrictions In Medicare Part D Surge As Demand For Obesity Drugs Grows
A major shift from unfettered coverage to prior authorizations was recorded by MMIT over the past year for the leading GLP-1/GIP agonist diabetes drugs. Public interest in using the drugs off label for weight loss drove the change.